Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosella Abeti

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Neurochemical Research|October 19, 2012
Activation of PARP by oxidative stress induced by β-amyloid: implications for Alzheimer's diseaseRosella Abeti, Michael R Duchen
Pharmacological Research|May 28, 2015
Mitochondrial Ca(2+) in neurodegenerative disordersRosella Abeti, Andrey Y Abramov
Brain : a Journal of Neurology|May 28, 2011
Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal deathRosella Abeti, Andrey Y Abramov, Michael R Duchen
Frontiers in Cellular Neuroscience|August 2, 2018
Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich's Ataxia ModelsRosella Abeti, Annalisa Baccaro, Noemi Esteras, et al.
Frontiers in Cellular Neuroscience|October 19, 2018
Calcium Deregulation: Novel Insights to Understand Friedreich's Ataxia PathophysiologyRosella Abeti, Alexander F Brown, Marta Maiolino, et al.
International Journal of Molecular Sciences|November 13, 2021
Hsp90 Inhibition: A Promising Therapeutic Approach for ARSACSSuran Nethisinghe, Rosella Abeti, Maheswaran Kesavan, et al.
Biochimica Et Biophysica Acta|March 10, 2009
IF1, the endogenous regulator of the F(1)F(o)-ATPsynthase, defines mitochondrial volume fraction in HeLa cells by regulating autophagyMichelangelo Campanella, Andreas Seraphim, Rosella Abeti, et al.
Pharmacological Research|July 5, 2015
Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxiaRosella Abeti, Ebru Uzun, Indhushri Renganathan, et al.
Autophagy|December 4, 2014
TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality controlJemma Gatliff, Daniel East, James Crosby, et al.
British Journal of Pharmacology|December 1, 2018
Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptomsRosella Abeti, Anna Zeitlberger, Colm Peelo, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Neurochemical Research|October 19, 2012
Activation of PARP by oxidative stress induced by β-amyloid: implications for Alzheimer's diseaseRosella Abeti, Michael R Duchen
Pharmacological Research|May 28, 2015
Mitochondrial Ca(2+) in neurodegenerative disordersRosella Abeti, Andrey Y Abramov
Brain : a Journal of Neurology|May 28, 2011
Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal deathRosella Abeti, Andrey Y Abramov, Michael R Duchen
Frontiers in Cellular Neuroscience|August 2, 2018
Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich's Ataxia ModelsRosella Abeti, Annalisa Baccaro, Noemi Esteras, et al.
Frontiers in Cellular Neuroscience|October 19, 2018
Calcium Deregulation: Novel Insights to Understand Friedreich's Ataxia PathophysiologyRosella Abeti, Alexander F Brown, Marta Maiolino, et al.
International Journal of Molecular Sciences|November 13, 2021
Hsp90 Inhibition: A Promising Therapeutic Approach for ARSACSSuran Nethisinghe, Rosella Abeti, Maheswaran Kesavan, et al.
Biochimica Et Biophysica Acta|March 10, 2009
IF1, the endogenous regulator of the F(1)F(o)-ATPsynthase, defines mitochondrial volume fraction in HeLa cells by regulating autophagyMichelangelo Campanella, Andreas Seraphim, Rosella Abeti, et al.
Pharmacological Research|July 5, 2015
Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxiaRosella Abeti, Ebru Uzun, Indhushri Renganathan, et al.
Autophagy|December 4, 2014
TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality controlJemma Gatliff, Daniel East, James Crosby, et al.
British Journal of Pharmacology|December 1, 2018
Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptomsRosella Abeti, Anna Zeitlberger, Colm Peelo, et al.
Pageof 3